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Abstract
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This study investigated whether reduced glutathione (GSH) was able to alter the negative effects of
tributyltin (TBT) or dibutyltin (DBT) on the lytic function of human natural killer (NK) cells. NK
cells are an intital immune defense against the development of tumors or viral infections. TBT and
DBT are widespread environmental contaminants, due to their various industrial applications. Both
TBT and DBT have been shown to decrease the ability of NK cells to lyse tumor cells (lytic function).
The results indicated that the presence of GSH during exposure of NK cells to TBT or DBT
diminished the negative effect of the BT on the lytic function of NK cells. This suggests that
interaction TBT and DBT with functionally relevant sulfhydryl groups in NK cells may be part of
the mechanism by which they decrease NK lytic function.
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INTRODUCTION
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Tributyltin (TBT) was produced in large quantities for wood preservation, marine antifouling
paints, disinfection of circulating industrial cooling water, and slime control in paper mills
(Roper, 1992). Detectable levels of TBT have been found in fish (Kannan and Falandyz,
1997; Kannan et al, 1995a,b,c; Alzieu et al., 1989). It has also been found in plastic products
(baking parchments made from siliconized paper) that come in contact with food and was found
to transfer into cookies placed on TBT-containing baking parchments (Takahashi et al.,
1999). There is significant exposure of humans to TBT as evidenced by its detection in human
blood (Whalen et al., 1999; Kannan et al., 1999).
DBT is used as a stabilizer in the production of polyvinyl chloride (PVC) plastic products
(Roper, 1992) and has been found in some plastic food containers (Nakashima et al., 1990;
Yamada et al., 1993). It has also been used as a deworming agent in poultry and some poultry
products have been shown to contain measurable levels of DBT (Epstein et al., 1991). Drinking
water has also been reported to contain DBT due to leaching from PVC pipes (Sidiki et al.,
1996). Human exposure to DBT could come from poultry products (Epstein et al., 1991),
consuming beverages stored in PVC pipes during manufacture (Forsyth et al., 1992a,b), and
drinking water (Sidiki et al., 1996). DBT has also been found in human blood from donors
with no specific route of exposure other than what is found in the environment (Kannan et al.,
1999; Whalen et al., 1999). Exposure to DBT appears to disrupt normal embryonic
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development and to cause a variety of birth defects in rats including cleft mandible and fused
ribs (Ema et al., 1996; Noda et al., 1993). It has also been shown to cause atrophy of the thymus
and pancreatitis in exposed rats (Merkord et al., 1997; Pieters et al., 1994). Exposure of animals
to DBT may debilitate their immune function, making them more vulnerable to infectious
diseases (Kannan et al. 1997, 1998).
Natural Killer (NK) cells are a subset of lymphocytes that are capable of killing tumor cells,
virally infected cells and antibody-coated cells. They are defined by the absence of the T cell
receptor/CD3 complex and by the presence of CD56 and/or CD16 on the cell surface (Walzer
et al. 2005). NK cells are capable of killing tumor cells without prior sensitization, putting them
in the forefront of lymphocyte defense against tumor cells and virally infected cells (Vivier et
al., 2004; Wu and Lanier, 2003; Biron et al, 1989; Fleisher et al., 1982; Hanna, 1980; Kiessling
and Haller, 1978). Therefore, any chemical that can affect the ability of NK cells to recognize
and lyse a target cell, could potentially increase the risk of tumors and viral infections.
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Our laboratory has shown that TBT and DBT are able to significantly reduce the lytic function
of human NK cells (Dudimah et al., 2007a,b; Whalen et al., 1999). Reduced glutathione (GSH)
is a tri-peptide that serves as an electron donor in cells (Meister and Anderson, 1983). The
detrimental effects of TBT in tunicates and of DBT on ox heart mitochondria have been shown
to be alleviated by GSH (Cain et al., 1977; Cima and Ballarin, 2004). Thus, it is important to
examine whether GSH is able to reduce the demonstrated negative effects of BTs on the
function of human NK cells. Such an examination will aid in elucidation of the mechanism by
which BTs may be interfering with the important anti-tumor function of NK cells. Here we
determine if the negative effects of TBT and DBT on the lytic function of human NK cells can
be diminished by GSH.

MATERIALS AND METHODS
Isolation of NK cells
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Peripheral blood from healthy adult (male and female) volunteer donors was used for this study.
Buffy coats (source leukocytes) obtained from the American Red Cross (Portland, OR) were
used to prepare NK cells. Highly purified NK cells were obtained using a rosetting procedure.
Buffy coats were mixed with 0.8 mL of RosetteSep human NK cell enrichment antibody
cocktail (StemCell Technologies, Vancouver, British Columbia, Canada) per 45 mL of buffy
coat. The mixture was incubated for 25 min at room temperature (∼ 25° C) with periodic
mixing. Following the incubation, 7−8 mL of the mixture was layered onto 4 mL of FicollHypaque (1.077 g/mL) (MP Biomedicals, Irvine, CA) and centrifuged at 1200 g for 30 min.
The cell layer was collected and washed twice with phosphate buffered saline (PBS) pH 7.2
and stored in complete media (RPMI-1640 supplemented with 10% heat-activated BCS, 2
mM L-glutamine and 50 U penicillin G with 50 μg streptomycin/ml) at 1 million cells/mL. The
resulting cell preparation was >95% CD16+, and CD56+, 0% CD3+ by fluorescence
microscopy and flow cytometry (Whalen et al., 2002).
Chemical preparation
TBT and DBT were purchased from Aldrich Chemical Co. (Milwaukee, WI). DBT was
dissolved in dimethylsulfoxide (DMSO) (Sigma-Aldrich, St. Louis, MO) to give a stock
solution. TBT (Sigma-Aldrich) is a liquid at room temperature. TBT was dispersed initially in
double de-ionized water (ddH2O) to give a 1 mM solution. Desired concentrations of each of
the compounds were prepared by dilution of the stock into complete media containing 0.5%
gelatin (gelatin media) in place of the 10% bovine serum. Gelatin replaced BSA to avoid
binding of the hydrophobic compounds to serum albumin, which could interfere with their
delivery the cells. The final concentration of DMSO for DBT exposures did not exceed 0.01%.
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A stock solution of GSH (Fisher Scientific, Pittsburgh, PA) dissolved in ddH2O was prepared
just prior to addition to the cell culture. The initial stock was appropriately diluted into gelatin
media prior to addition to the cell cultures.
Cell Treatments
NK cells (at a concentration of 1.5 million cells/ mL) were exposed to 1 mM GSH either 1 h
prior to or at immediately prior to the addition of various concentrations of TBT or DBT or
control for 1 h, 24 h or 48 h. Following the exposures the cells were assayed tumor-destroying
function.
Cell Viability
Cell viability was determined by trypan blue exclusion. Cell numbers and viability were
assessed at the beginning and end of each exposure period. Viability was determined at each
concentration for each of the exposure periods. The viability of treated cells was compared to
that of control cells at each length of exposure (Whalen et al., 2002). Only those concentrations
where viability was unaffected were used at a given length of exposure.
Cytotoxicity assay
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The ability of NK cells to lyse tumor cells was measured using a 51Cr release assay (Whalen
et al., 1999). The target cell in all cytotoxicity assays was the NK-susceptible K562 (human
chronic myelogenous leukemia) cell line. K562 cells were incubated with 51Cr (Perkin-Elmer
Life Sciences, Boston, MA) in 0.2−0.5 ml of BCS for 1−1.5 h at 37 °C in air/CO2 (19:1).
Following this incubation the target cells were washed twice with gelatin media. NK (effector)
cells (1.2×105/100 μL for 12:1 ratio with target cells) were added to the wells of round-bottom
microwell plates. The effectors were diluted to 6:1 ratio (0.6×105/100 μL) and 3:1 ratio
(0.3×105/100 μL); each ratio was tested in triplicate. Target cells were added (1×104/100μL)
to each well of the microwell plate and the plate was centrifuged at 300g for 3.5 min and
incubated for 2 hr at 37 °C ( air/CO2 ,19:1). After incubation a 0.1 ml aliquot of the supernatant
was collected and counted for radioactivity for 60 sec in a Packard COBRA gamma radiation
counter (Packard Instrument Co., Meriden, CT). Target lysis was calculated as follows: 100×
[(test c.p.m - spontaneous c.p.m.)/maximum c.p.m.- spontaneous c.p.m.)]. Maximum release
was produced by adding 100 μL of 10% Triton X-100.
GSH assay
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The stability of exogenously added GSH under the culture conditions used was determined
using a glutathione colorimetric assay kit (BioVision, Mountain View, CA). Briefly, GSH was
added to gelatin media at a final concentration of 1 mM and incubated for 1 h, 24h, 48h or 6
days at 37°C, 19:1 Air:CO2. A volume of 20 μL of the culture solution was added to 160 μL
of reaction buffer and incubated for 10 min at room temperature (RT), 20 μL of substrate was
then added and incubated for 10 min at RT. Absorbance was read at 405 nM. Concentrations
of reduced GSH in the samples were determined using a standard curve.
14C-DBT

accumulation
Purified NK cells were exposed to 10 μM and 5 μM 14C-DBT for 1 h or 1 μM and 0.5
μM 14C-DBT for 24 h plus or minus 1 mM GSH. Following the exposures the cells were
centrifuged and the supernatant was removed and placed in an appropriately labeled
scintillation vial. The cell pellet was then resuspended in 500 μL of medium and centrifuged.
The supernatant was removed and added to the scintillation vial containing the initial
supernatant. This process was repeated. Following the wash step, 100 μL of 0.1 M NaOH was
added to the pellet and the dissolved pellet was transferred to a scintillation vial. The total
radioactivity added to the cells at a given DBT concentration was determined by adding that
Drug Chem Toxicol. Author manuscript; available in PMC 2010 January 1.
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same amount of 14C-DBT to a separate scintillation vial and counting it with the samples.
Results are given as μM DBT accumulated in the cells. The volume of the cells was estimated
using the number of NK cells that were present and multiplying that number by the volume of
an individual NK cell (approximately 7.35 × 10−10 mL) to get the total volume of the cells
(Whalen et al., 2008).
Statistical Analysis
Statistical analysis of the data was carried out utilizing ANOVA and Student's t test. Data were
initially compared within a given experimental setup by ANOVA. A significant ANOVA was
followed by pair wise analysis of control versus exposed data using Student's t test.

RESULTS
Effect of GSH added immediately prior or 1 h prior to TBT exposures on the TBT-induced
inhibition of NK cell lytic function

NIH-PA Author Manuscript

GSH (1 mM) was added to NK cells either immediately or 1 h prior to a 1 h, 24 h, or 48 h
exposure to various concentrations of TBT. Figure 1A shows that a 1 h exposure to 500 nM
TBT decreased NK lytic function by greater than 90% and 300 nM TBT caused a 67.5%
decrease . However, when 1 mM GSH was added to the NK cell just before the addition of the
TBT, 500 nM TBT was able to decrease lytic function by only 29% and 300 nM decreased
function by only 13.7%. There was very significant protection of lytic function at both
concentrations of TBT (P< 0.00001). A 1h pre-incubation with GSH prior to adding the TBT
diminished the effectiveness of the GSH at protecting against 500 nM TBT but did not
significantly decrease its effectiveness at protecting against 300 nM TBT.
When NK cells were exposed to 200 nM, 100 nM , or 50 nM TBT for 24 h the losses of lytic
function were 89.4%, 59.1%, and 25%, respectively. The presence of 1 mM GSH during the
exposure to TBT for 24h diminished the negative effects of the TBT to a significant (P<0.02)
extent at 100, and 50 nM TBT (Figure 1B). However, the extent of protection was greatest at
the 100 nM exposure where the cells that received 1 mM GSH prior to TBT exposure showed
a 22.8% loss of lytic function as compared to the nearly 60% loss of function in the absence
of GSH (Figure 1B). Effects were similar whether the GSH was added immediately prior to
TBT exposure or 1h prior.
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A 48 h exposure to 100 nM or 50 nM TBT decreased the lytic function of NK cells by 72.9%
and 42.8%, respectively (Figure 1C). There was some significant protective effect of having
added GSH. The decrease at 100 nM went from about 73% to only 53% (P<0.04). The decrease
in effectiveness of GSH is likely due to the fact that the GSH has been oxidized under the
incubation conditions such that essentially no reduced GSH remains after 48h. This was
determined by incubating GSH in cell culture medium for 48 h and assaying for reduced GSH
(data not shown).
Effect of GSH added immediately prior or 1 h prior to DBT exposures on the DBT-induced
inhibition of NK cell lytic function
GSH (1 mM) was added to NK cells either immediately or 1 h prior to a 1 h, 24 h, or 48 h
exposure to various concentrations of DBT. Exposure to 10 μM DBT decreased NK lytic
function by 83% and 5 μM DBT caused a 41.8% decrease . When 1 mM GSH was present at
the time of the addition of the DBT, 10 μM DBT was able to decrease lytic function by only
9% and 5 μM did not decrease function at all (Figure 2A). There was very significant protection
of lytic function from the DBT-induced decreases in function by GSH (P< 0.00001). A 1h preincubation with GSH prior to adding the DBT showed essentially the same results as were seen
with no pre-incubation.
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NK cells exposed to 1 μM or 0.50 μM DBT for 24 h showed decreases in lytic function of
93.1% and 67.1%, respectively (Figure 2B). The presence of 1 mM GSH during the exposure
to DBT for 24h diminished the negative effects at both DBT concentrations to a significant
extent (P<0.00001). When GSH was present during the exposure to 1 μM DBT the decrease
in lytic function was only 26.6% and there was no decrease seen with 0.5 μM DBT (Figure
2B). Effects were similar whether the GSH was added immediately prior to DBT exposure or
1h prior.
Exposures of NK cells to 1 μM or 0.50 μM DBT for 48 h decreased the lytic function by 94.6%
and 50.8%, respectively (Figure 2C). There was some significant protective effect of having
added GSH. The decrease with1 μM went from about 95% to 60% (P<0.01) and the decrease
seen with 0.5 μM was only 11% as compared to 50.8% in the absence of GSH. However, there
did seem to be somewhat of decrease in effectiveness after 48h (Figure 2D).
Effect of GSH on the uptake of DBT by NK cells
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The ability of GSH to prevent DBT from entering NK cells, as a mechanism for its effect on
decreasing the toxicity of DBT, was examined using a 14C-DBT. Figure 3A shows the uptake
of 10 μM and 5 μM at 1h in NK cells with and without added GSH (1 mM). The uptake was
not significantly affected by the presence of 1 mM GSH at either of the DBT concentrations.
Figure 3B shows the effect of GSH on the uptake of 1 μM and 0.5 μM DBT by NK cells after
a 24 h incubation. Again, there was no statistically significant alteration of DBT uptake when
1mM GSH was present in the incubation.

DISCUSSION
Past studies have shown that sulfydryl containing compounds such as GSH were able to block
the negative effects of TBT on the function of phagocytes in tunicates (Cima and Ballarin,
2004) as well as the negative effects of DBT on oxidative phosphorylation (Cain et al.,
1977). Additionally, the ability of TBT to directly interact with sulfydryl groups has been
demonstrated using column chromatography (Wronski, 1976). Previously, we had shown that
both TBT and DBT were able to decrease the lytic function of human NK cells (Dudimah et
al., 2007a,b; Whalen et al., 1999). The current study examined the capacity of exogenous GSH
to alleviate the negative effects of both TBT and DBT on the lytic function of human NK cells.
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The decreases in lytic function that occurred after 1 h, 24 h, and 48 h exposures of NK cells to
TBT were diminished when GSH was present in the incubation medium. The protective effect
of the GSH was not enhanced by allowing the cells to pre-incubate with the GSH before adding
the TBT. The protective effect of the GSH on NK lytic function was consistent with the results
of past studies showing that GSH was protective of hemocytes from B. Schlosseri (Cima and
Ballarin, 2004). Additionally, we found that as the reduced GSH levels decreased presumably
due to oxidation that the protective effect also decreased (the protective effect was greatest for
a 1 h exposure to TBT and least for a 48 h exposure to TBT). This suggested that the direct
interaction of the TBT with the sulfhydryl group of GSH may be responsible for the protective
effect, possibly by preventing the TBT from interacting with sulfhydryl groups in biomolecules
important to the function of the NK cell. As mentioned above, direct interaction of TBTwith
sulfhydryl groups has been demonstrated (Wronski, 1976).
NK cells exposed to DBT showed dramatic decreases in lytic function at each time point that
was examined (1 h, 24 h, 48 h). The presence of GSH in the incubation medium had a very
significant protective effect on lytic function. As with TBT, there was no advantage seen when
the GSH was added 1 h prior to the addition of the DBT. However, the capacity of the GSH
to diminish the negative effects of DBT on NK lytic function was greater with DBT than with
TBT. For example, a 1 h exposure to the highest concentration of TBT caused an 89% loss of
Drug Chem Toxicol. Author manuscript; available in PMC 2010 January 1.
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lytic function which was reduced to 29% when GSH was present, while the highest
concentration of DBT caused an 83% decrease in function which was decreased to only 9% in
the presence of GSH. This same trend was true at other concentrations and lengths of
incubation. This suggested that the interaction of DBT with GSH may be stronger than that of
TBT. This may be in part due to the fact that the tin atom of DBT is less sterically hindered in
terms of being able to coordinate with an additional atom (such as the sulfur of GSH) than that
of TBT (Smith and White, 1972).
We found that the antioxidant vitamin E had no remedial effect on the butyltin-induced loss
of NK lytic function, suggesting that the potential interaction with the sulfur group and not the
antioxidant effect of GSH was important in its ability to diminish the negative effects of the
organotins. Finally we found that GSH in the incubation medium did not decrease the uptake
of DBT by NK cells, which would have been a possible explanation for its ability to spare NK
lytic function.

CONCLUSIONS
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TBT- and DBT-induced decreases in the lytic function of human NK cells can be decreased
by the presence of reduced glutathione in the incubation medium during exposure to the
compounds. The ability of GSH to protect NK cells from the negative effects of DBT was
greater than for TBT. The protective effect of GSH did not appear to be simply due to its
capacity to act as an antioxidant. Finally, the capacity of GSH to form a complex with the
organotins and prevent their entry into the NK cell did not appear to be the explanation for the
protection that it exerted.
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Figure 1.
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Effect of 1 mM GSH on the TBT-induced decreases in NK lytic function. A.) NK cells were
exposed to either 500 nM or 300 nM TBT for 1 h in the absence (black bars) or presence of 1
mM GSH, which was added immediately prior (dark gray bars) to or 1 h in advance of (light
gray bars) the addition of the TBT. * indicates a statistically significant difference from cells
exposed to TBT in the absence of GSH (P<0.00001). B.) NK cells were exposed to 200 nM,
100 nM, or 50 nM TBT for 24 h in the absence or presence of GSH, as described above for the
1 h exposure. * indicates a statistically significant difference from cells exposed to TBT in the
absence of GSH(P<0.02). C.) NK cells were exposed to 100 nM or 50 nM TBT for 48 h in the
absence or presence of GSH, as described for the 1 h exposure. * indicates a statistically
significant difference from cells exposed to TBT in the absence of GSH (P<0.04). The
concentrations of TBT tested at each length of exposure were based on prior studies (Dudimah
et al. 2007b) and the fact that these concentrations do not decrease the viability of NK cells at
those lengths of exposure. Data are the mean±S.D. for a minimum of 9 determinations from a
minimum of three individual donors.
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Figure 2.

Effect of 1 mM GSH on the DBT-induced decreases in NK lytic function. A.) NK cells were
exposed to either 10 μM or 5 μM DBT for 1 h in the absence (black bars) or presence of 1 mM
GSH, which was added immediately prior (dark gray bars) to or 1 h in advance of (light gray
bars) the addition of the DBT. * indicates a statistically significant difference from cells
exposed to TBT in the absence of GSH (P<0.00001). B.) NK cells were exposed to 1 μM or
0.50 μM DBT for 24 h in the absence or presence of GSH, as described above for the 1 h
exposure. * indicates a statistically significant difference from cells exposed to TBT in the
absence of GSH (P<0.00001). C.) NK cells were exposed to 1 μM or 0.50 μM DBT for 48 h
in the absence or presence of GSH, as described for the 1 h exposure. * indicates a statistically
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significant difference from cells exposed to TBT in the absence of GSH (P<0.01). D.) Shows
the results of exposures to 1 μM DBT in the absence and presence of 1 mM GSH (no
preincubation) as a function of the length of exposure. The concentrations of DBT tested at
each length of exposure were based on prior studies (Dudimah et al. 2007a) and the fact that
these concentrations do not decrease the viability of NK cells at those lengths of exposure.
Data are the mean±S.D. for a minimum of 9 determinations from a minimum of three individual
donors.
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Figure 3.

Effect of 1 mM GSH on the accumulation of DBT by NK cells. A.) NK cells were exposed to
either 10 μM or 5 μM DBT for 1 h in the absence (black bars) or presence (gray bars) of 1 mM
GSH, which was added immediately prior the addition of the DBT. Uptake was determined
using 14C-labelled DBT as described in Whalen et al. 2008. B.) NK cells were exposed to either
1 μM or 0.5 μM DBT for 24 h in the absence (black bars) or presence (gray bars) of 1 mM
GSH, which was added immediately prior the addition of the DBT. Data are the mean±S.D.
for 9 determinations at 1 h and 6 determinations at 24 h from a minimum of three individual
donors.
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